BDTX - Black Diamond Therapeutics, Inc.
IEX Last Trade
2.23
-0.080 -3.587%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:10 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$2.31
-0.08
-3.46%
Summary score
27%
Profitability
41%
Dept financing
18%
Liquidity
50%
Performance
8%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
11.26%
Return on assets
-6.07%
Return on sales
0%
Return on invested capital
211.15%
Total debt ratio
82.59%
Debt ratio change over timeo
-0.6%
Current Ratio
30.52%
Quick Ratio
0%
Cash Position Ratio
25.63%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
9.14%
Return on assets
-6.12%
Return on sales
0%
Return on invested capital
232.44%
Total debt ratio
70.74%
Debt ratio change over timeo
-0.6%
Current Ratio
33.13%
Quick Ratio
0%
Cash Position Ratio
27.02%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-4.25%
Return on assets
-4.3%
Return on sales
0%
Return on invested capital
-10.79%
Total debt ratio
1.81%
Debt ratio change over time
-0.99%
Current Ratio
33.92%
Quick Ratio
0%
Cash Position Ratio
10.42%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-94.53%
Return on assets
-103.3%
Return on sales
0%
Return on invested capital
6.8%
Total debt ratio
-59.98%
Debt ratio change over time
-0.6%
Current Ratio
12.31%
Quick Ratio
0%
Cash Position Ratio
9.06%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BDTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 11.26% | -3.05% | 11.55% | 6.27% |
| Return on assets | -6.07% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 211.15% | 5.09% | 7.99% | 13.19% |
| Profitability | 49% | 37% | 68% | 60% |
| Total debt ratio | 82.59% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.6% | 6.09% | 6.03% | 1.53% |
| Dept financing | 20% | 50% | 43% | 14% |
| Current Ratio | 33.13% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 27.02% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 12% | 29% | 27% |
| Short-term ratios | BDTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 9.14% | -25.62% | 17.94% | 7.14% |
| Return on assets | -6.12% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 232.44% | 8.14% | 7.17% | 18.16% |
| Profitability | 38% | 39% | 70% | 59% |
| Total debt ratio | 70.74% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.6% | -23.44% | 9.66% | 0.6% |
| Dept financing | 17% | 25% | 45% | 8% |
| Current Ratio | 33.13% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 27.02% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 20% | 17% | 29% |